February 2014
-
Venture Capital in Life Sciences (I): Personalized Medicine for Cancer Therapies
Over the past decade, the genomics revolution has led to the emergence of numerous groundbreaking personalized medicine as well as multiple diagnostic and therapeutic targets. Take the area of cancer therapies for instance, due to great inter-personal difference and mechanism of drug sensitivity in patients, cancer is one of the diseases that have lowest productivity… Continue reading
-
Healthcare Investing: In Innovators We Trust, Up to the Future We Light
When people talk about “healthcare,” they probably refer to pharmaceuticals and health insurers, but the sector also covers life sciences and biotechnology, medical equipment manufacturers and services, hospitals, distributors, etc. My firm conducted a due diligence trip to China and visited many scientists of these fields in Beijing, Shanghai, and some southern cities in January… Continue reading
-
Crowdfunding: A Powerful Model of Fundraising 众筹融资
Crowdfunding is an internet-based fundraising model, where individuals network and pool their money to support a certain project or venture. A crowdfunding activity is composed of a project creator, crowd or the public who will support the project or venture, and a crowdfunding platform. The “crowd” act as agents, selecting and promoting the projects in… Continue reading
-
Alternative Investments of 2013: Bitcoin, Yu’ebao, Tourmaline 比特币 余额宝 碧玺
Innovation almost always comes first with alternative investments, even if a type of alternative asset class may sound bizarre to conventional investors. Looking back at the year of 2013, many alternative investments such as bitcoin, yu’ebao (Leftover Treasure), Mobile Browser Keywords, gemstones etc. occupied most news headlines. Investors cannot estimate the true risk of alternative… Continue reading
Archive
- February 2023
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- April 2022
- March 2022
- February 2022
- July 2021
- June 2021
- November 2020
- December 2018
- June 2018
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- March 2016
- November 2015
- October 2015
- September 2015
- July 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
Category
- Alternative Investments
- Asset Allocation
- Behavioral Finance
- Buyout
- Commodities
- Due Diligence
- Emerging Markets
- Energy
- ESG
- Farmland
- Financial Modeling
- Fixed Income
- Global Equity
- Global Macro
- Healthcare Fund
- Hedge Funds
- High Yield Bonds
- Investment Vehicle
- Life Sciences
- Managed Futures
- Market Commentary
- MENA
- Natural Resources
- Portfolio Management
- Precious Metals
- Private Equity
- Private Wealth
- Real Assets
- Real Estate
- Risk Management
- Socially Impact Investing
- Technical Analysis
- The Endowment Model
- Timberland
- Value Equity
- Venture Capital
DR.CHENJIAZI ZHONG 